Vimarsana
Biggest News Aggregation in the World

Page 39 - Chumakov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chumakov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chumakov Today - Breaking & Trending Today

COVID-19: World passes 200 million vaccine doses - Vimarsana News

COVID-19: World passes 200 million vaccine doses

Israel is far ahead of any other country worldwide with almost half its population having received at least one vaccine dose.

Source: ewn.co.za
Inoculation against coronavirus with CoviVac contraindicated during pregnancy - Vimarsana News

Inoculation against coronavirus with CoviVac contraindicated during pregnancy

According to the manual, other contraindications include severe allergic reactions

Source: tass.com
Russia approves its third COVID-19 vaccine - CoviVac - Vimarsana News

Russia approves its third COVID-19 vaccine - CoviVac

20 Feb in 10:20 Russia on Saturday approved the third coronavirus vaccine for domestic use, Russin Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot have yet to begin. The vaccine, dubbed CoviVac, has been developed by the Chumakov Scientific Center in Moscow. "Today, Russia is the only country to have already three vaccines against COVID-19," Prime Minister Mishustin said. The first 120,000 doses will be released for domestic use in March. The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal fridge tempe...

Russia approves its third COVID-19 vaccine - Vimarsana News

Russia approves its third COVID-19 vaccine

The first 120,000 doses, labelled CoviVac and produced by the Chumakov Centre, will be released for domestic use in March

Russia approves third COVID-19 vaccine - CoviVac, says PM Mikhail Mishustin - Vimarsana News

Russia approves third COVID-19 vaccine - CoviVac, says PM Mikhail Mishustin

Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results

Source: msn.com